Obesity might undermine treatment for breast cancer
Cancer Breast Cancer Obesity

Obesity might undermine treatment for breast cancer

Flávia Oliveira Geraldes
Flávia Oliveira Geraldes

In 10 seconds? Researchers have found that high concentrations of a hormone called leptin – secreted by fat cells – might hamper the effectiveness of tamoxifen, a common breast cancer treatment, putting into focus the need to improve therapy for obese patients.

What hormone is that? Often called the “satiety hormone” (or the “obesity hormone”, or the “starvation hormone”, depending on whom you ask), leptin is known for its intervention in the regulation of hunger. It is produced by fat-storing cells (adipocytes) to signal the brain that the body has sufficient fat reserves.

Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Personal

$99/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access 4 topic areas of your choosing
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
❌ Direct access to the Expert Network
❌ Your questions - answered by an Expert Scientist
❌ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
❌ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Professional

$3499/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
✅ Direct access to the Expert Network
✅ Your questions - answered by an Expert Scientist
✅ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
✅ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial